Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features

Blood

Volumn 95, Issue 12, 2000, Pages 3878-3884

  Miklos, John A ^a   Swerdlow, Steven H ^a   Bahler, David W ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME;

EID: 0034660310     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3878     Document Type: Article

References (44)

1. Harris NL. Lymphoid proliferations of the salivary glands. Am J Clin Pathol. 1999;111(suppl 1):S94.
2. Hyjek E, Smith WJ, Isaacson PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol. 1988; 19:766.
3. Kipps TJ, Tomhave E, Chen PP, Fox RI. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjögren's syndrome. J Immunol. 1989;142:4261.
4. Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalingant antigen-selected expansions. Blood. 199B;91: 1864.
5. Bahler DW, Miklos JA, Swerdlow SH. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood. 1997;89:3335.
6. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today. 1995;16: 237.
7. Sasso EH, Johnson T, Kipps TS. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. J Clin Invest 1996;97:2074.
8. Sasso EH, van Dijk KW, Bull AP, Milner ECB. A fetally expressed immunoglobulin V H1 gene belongs to a complex set of alleles. J Clin Invest. 1993;91:2358.
9. Brezinschek HP, Brezinschek RI, Dorner T, Lipsky PE. Similar characteristics of the CDR3 of VH1-69/DP10 rearrangements in normal human peripharal blood and chronic lymphocytic leukaemia B cells. Br J Haematol. 1998;1998:516.
10. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH 1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235.
11. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515.
12. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848.
13. Li Y, Spellerberg MB, Stevenson FK, Capra JD, Potter KN. The I binding specificity of human VH4-34 (VH4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol. 1996;256:577.
14. Martin T, Duffy SF, Carson DA, Kipps TJ. Evidence for somatic selection of natural autoantibodies. J Exp Med. 1992;175:983.
15. Quintana PG, Kapadia SB, Bahler DW, Johnson JT, Swerdlow SH. Salivary gland lymphoid infiltrates associated with lymphoepithelial lesions: a clinicopathologic, immunophenotypic, and genotypic study. Hum Pathol. 1997;28:850.
16. Lister J, Miklos JA, Swerdlow SH, Bahler DW. A clonally distinct recurrence of Burkitt's lymphoma at 15 years. Blood. 1996;88:1407.
17. Diss TC, Pan L, Wotherspoon AC, Isaacson PG. Sources of DNA for detecting B cell monoclonality using PCR. J Clin Pathol. 1994;47:493.
18. Sioutos N, Bagg A, Michaud GY, et al. Polymerase chain reaction versus Southern blot hybridization detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol. 1995; 4:8.
19. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996;10:1190.
20. Qin Y, Greiner A, Trunk M, Schmausser B, Ott M, Muller-Hermelink H. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995;86:3528.
21. Du M-Q, Xu C-F, Diss TC, et al. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood. 1996;88:4445.
22. Chapman C, Dunn-Walters D, Stevenson F, Hussell T, Isaacson P, Spencer J. Sequence analysis of immunoglobulin variable region genes that encode autoantibodies expressed by lymphomas of mucosa associated lymphoid tissue. JCP Clin Mol Pathol. 1996;49:M29.
23. Hallas C, Greiner A, Peters K, Muller-Hamerlink HK. Immunoglobulin VH genes of high-grade mucossa-associated lymphoid tissue lymphomas show a high load of somatic mutations and evidence of antigen-dependent affinity maturation. Lab Invest. 1998;79:277.
24. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol. 1991;147:1720.
25. Borretzen M, Chapmen C, Stevenson FK, Natvig JB, Thompson KM. Structural analysis of VH4-21 encoded human IgM allo-and autoantibodies against red blood cells. Scand J Immunol. 1995; 42:90.
26. Mariette X, Brauet JC, Danon F, Tsapis A, Lassoued K. Nucleotide sequence analysis of the VL and VH domains of five human IgM directed to lamin B. Arthritis Rheum. 1993;36: 1315.
27. Adderson E, Shackelford P, Quinn A, et al. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. J Clin Invest. 1993;91:2734.
28. Borretzen M, Randen I, Natvig JB, Thompson KM. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J Immunol. 1995;155:3630.
29. Anderson L, Cummings N, Asofsky R, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome: nature history and response to treatment. Am J Med. 1972;53: 456.
30. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM. Cryoglobulinemia in autoimmune rheumatic diseases. Arthritis Rheum. 1986;29:1098.
31. Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today. 1994;15:367.
32. Schlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature. 1987;328:805.
33. Denepoux S, Razanajaona D, Blanchard D, et al. Induction of somatic mutation in a human B cell line in vitro. Immunity. 1997;6:35.
34. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998;91:2433.
35. Jaffe ES, Narris NL, Diebold J, Muller-Hamerlink HK. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol. 1999;111(suppl 1):s8.
36. Angeld V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490.
37. Gorevic PD, Frangione B. Mixed cryoglobulin crossreactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative disease. Semin Hematol. 1991;28:79.
38. Aceti A, Talianai G, Sorice M, Amendolea MA. HCV and Sjögren's syndrome. Lancet. 1992;339: 1425.
39. Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766.
40. Deacon EM, Matthews JB, Potts AJC, Hamburger J, Mageed A, Jefferis R. Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol. 1991;83:280.
41. Borretzen M, Randen I, Zdarsky E, Forre O, Natvig JB, Thompson KM. Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions. Proc Natl Acad Sci U S A. 1994;91:12917.
42. Williams RC Jr, Malone CC, Kao K-J. IgM rheumatoid factors react with human class I HLA molecules. J Immunol. 1996;156:1684.
43. Thorpe SJ, Borretzen M, Bailey SW, Randen I, Natvig JB, Thompson KM. Human monoclonal rheumatoid factors: incidence of cross-reactions with tissue components and correlation with VH gene usage. Immunology. 1994;83:114.
44. Thompson KM, Randen I, Borretzen M, Forre O, Natvig JB. Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization. Eur J Immunol. 1994;24:1771.